23andMe Holding Co. (ME) Financials
Stock symbol ME is outdated, potentially delisted? Maybe it is available on other exchange?
ME Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2024 | 318.9 million | 217.0 million |
| June 30, 2024 | 368.0 million | 224.5 million |
| March 31, 2024 | 395.2 million | 206.6 million |
| Dec. 31, 2023 | 608.2 million | 231.0 million |
ME Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2024 | -58.5 million | 23.7 million |
| June 30, 2024 | -44.6 million | 21.6 million |
| March 31, 2024 | -19.2 million | 19.0 million |
| Dec. 31, 2023 | -14.1 million | 26.4 million |
ME Net Income
No data available :(
ME Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2024 | 126.6 million | 62.4 million | - |
| June 30, 2024 | 171.5 million | 65.2 million | 74.2 million |
| March 31, 2024 | 217.9 million | 67.8 million | 76.5 million |
| Dec. 31, 2023 | 242.4 million | 140.9 million | 78.8 million |
ME Shares Outstanding
ME Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2024 | 1.1 million | 41.0 million | 40.3 million | 16.9 million |
| June 30, 2024 | 1.3 million | 42.8 million | 46.5 million | 8.6 million |
| March 31, 2024 | 2.2 million | 46.7 million | 39.2 million | 10.5 million |
| Dec. 31, 2023 | 2.0 million | 41.7 million | 57.2 million | 21.6 million |
ME Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2024 | 44.1 million | 21.7 million |
| June 30, 2024 | 40.4 million | 25.7 million |
| March 31, 2024 | 64.0 million | 37.0 million |
| Dec. 31, 2023 | 44.7 million | 24.8 million |
ME Revenue by Segment
Graph available only for paid members. Upgrade to see it.
ME
Price: $0.61
52 week price:
Earnings Per Share: -17.39 USD
P/E Ratio: -0.03
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.6 million
Market Capitalization: 13.3 million